Valneva SE (VALN) Inventory Average (2022 - 2026)
Valneva SE (VALN) posted quarterly Inventory Average of $57.4 million for Q1 2026, down 12.59% year-on-year from $65.6 million in Q1 2025, and down 11.97% on a QoQ basis from $65.2 million in Q4 2025.
Valneva SE (VALN) Inventory Average (2022 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Inventory Average for 5 consecutive years, with $57.4 million the latest figure, recorded in Q1 2026.
- Quarterly Inventory Average fell 12.59% year-over-year to $57.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.4 million (down 12.59% YoY) and the FY2025 annual result came in at $59.1 million, up 5.88% from the prior year.
- Inventory Average declined to $57.4 million in Q1 2026 per VALN's latest filing, from $65.2 million in the prior quarter.
- Over the last five years, Inventory Average for VALN reached as high as $150.1 million in Q1 2022 and fell as low as $40.6 million in Q3 2023.
- A 5-year average of $70.7 million and a median of $63.4 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2023 — Inventory Average sank 71.91% — and 2024, when it jumped 49.53%.
- Year by year, Inventory Average stood at $74.9 million in 2022, then tumbled by 37.32% to $46.9 million in 2023, then soared by 35.2% to $63.4 million in 2024, then climbed by 2.72% to $65.2 million in 2025, then declined by 11.97% to $57.4 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $57.4 million, $65.2 million, and $71.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 57.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.36 Mn |
| Dec 31, 2025 | 65.16 Mn |
| Sep 30, 2025 | 71.70 Mn |
| Jun 30, 2025 | 70.22 Mn |
| Mar 31, 2025 | 65.63 Mn |
| Dec 31, 2024 | 63.44 Mn |
| Sep 30, 2024 | 60.71 Mn |
| Jun 30, 2024 | 55.45 Mn |
| Mar 31, 2024 | 52.94 Mn |
| Dec 31, 2023 | 46.92 Mn |
| Sep 30, 2023 | 40.60 Mn |
| Jun 30, 2023 | 41.17 Mn |
| Mar 31, 2023 | 42.16 Mn |
| Dec 31, 2022 | 74.86 Mn |
| Sep 30, 2022 | 109.05 Mn |
| Jun 30, 2022 | 133.67 Mn |
| Mar 31, 2022 | 150.11 Mn |